Z22.330 Carrier of Group B streptococcus

Name of the Condition

• Carrier of Group B streptococcus

Summary

This code identifies individuals who harbor Streptococcus agalactiae (Group B streptococcus) without exhibiting symptoms of the associated disease. Carriers may transmit the bacteria to others, even without clinical signs of illness. The designation is used to document exposure risk and guide public health or clinical management.

Causes

Carriership occurs when an individual harbors Streptococcus agalactiae without developing symptoms. This can result from prior infection, asymptomatic colonization, or incomplete pathogen clearance. The bacteria typically colonize the gastrointestinal or genitourinary tract, and transmission occurs through direct contact or environmental exposure.

Risk Factors

• Close contact with infected individuals or contaminated environments.
• Pregnancy (increased risk of vertical transmission).
• Age (neonates, elderly, or immunocompromised individuals may be more susceptible).
• Underlying health conditions (e.g., diabetes, chronic illness).
• Prior exposure to Group B streptococcus in healthcare or community settings.

Symptoms

Not applicable; carriers typically show no signs of illness. However, some may experience mild or transient symptoms that resolve without treatment.

Diagnosis

Diagnosis involves laboratory testing (e.g., cultures, molecular assays) to detect Streptococcus agalactiae. Screening may be prompted by exposure history, public health guidelines, or routine testing in high-risk populations (e.g., pregnant individuals).

Treatment Options

Antibiotic prophylaxis may be recommended for carriers in specific scenarios (e.g., pregnancy to prevent neonatal transmission). Treatment is not always required for asymptomatic carriers unless complications arise.

Prognosis and Follow-Up

Most carriers remain asymptomatic and do not develop disease. Follow-up may involve repeat testing to monitor colonization status, especially in high-risk groups (e.g., pregnant individuals).

Complications

Complications are rare in asymptomatic carriers but may include invasive infections (e.g., sepsis, pneumonia) in vulnerable populations (e.g., neonates, immunocompromised individuals).

Lifestyle & Prevention

• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Follow public health recommendations for screening during pregnancy.
• Avoid sharing personal items (e.g., towels, utensils) in close-contact settings.
• Maintain overall health to support immune function.

When to Seek Professional Help

Seek care if symptoms of infection develop (e.g., fever, pain, or signs of sepsis) or if exposure to Group B streptococcus is suspected in high-risk scenarios (e.g., pregnancy).

Tips for Medical Coders

Document the presence of Streptococcus agalactiae colonization without symptoms to support this code. Include clinical context (e.g., screening during pregnancy) and any relevant exposure history. Ensure documentation aligns with coding guidelines for asymptomatic carriership.